Kirkland & Ellis LLP and Cole Schotz P.C. have represented Multi-Color Corporation. Debevoise & Plimpton LLP and Latham & Watkins LLP have advised CD&R. Milbank LLP...
Multi-Color Corporation Completes $6 Billion Financial Restructuring and Recapitalization
Long Lake Management to Acquire Amex GBT in $6.3 Billion Take-Private Transaction
Skadden and Macfarlanes have advised American Express Global Business Travel. Kirkland & Ellis has advised the Special Committee of the Board of American Express Global Business...
Blackstone to Acquire Champions Group from Odyssey Investment Partners
Weil, Gotshal & Manges has advised Blackstone. Latham & Watkins LLP has advised Odyssey Investment Partners. Blackstone, through its funds managed by Blackstone’s perpetual private equity...
Immunovant Raises $550 Million in Common Stock Offering
Sidley Austin LLP has advised Immunovant, Inc. Latham & Watkins LLP has advised the underwriter. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company focused on developing...
CoreWeave’s $2 Billion Upsized IPO
Fenwick & West represented CoreWeave, Inc. in the offering, and Latham & Watkins represented the underwriters. CoreWeave, Inc. (Nasdaq: CRWV), a developer of a cloud infrastructure...
Brookfield and Antin’s $1 Billion Investment in Origis Energy
Vinson & Elkins advised Brookfield Asset Management Ltd. on the transaction, and Latham & Watkins advised Origis Energy. Origis USA (a portfolio company of Antin Infrastructure...
BC Partners’ Sale of Majority Stake in GardaWorld
Simpson Thacher & Bartlett is representing Garda World Security Corporation (“GardaWorld”), Founder, Chairman and CEO Stephan Crétier, and GardaWorld management, while Latham & Watkins acted as...
Immunovant’s US$450 Million Common Stock Financing
Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
Turnstone Biologics Corp.’s $80 Million Initial Public Offering
Cooley represented Turnstone, and Latham & Watkins represented the underwriters in the IPO. Turnstone Biologics Corp. (Nasdaq: TSBX) announced the pricing of its upsized initial public...
Acumen’s $130 Million Common Stock Public Offering
Ropes & Gray advised Acumen, and Latham & Watkins advised the underwriters. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced the pricing of an upsized underwritten public offering of...
Zentalis Pharmaceuticals’ $250 Million Underwritten Offering of Common Stock
Latham & Watkins represented Zentalis in the offering, and Cooley represented the underwriters. Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) announced the pricing of an underwritten offering of...
U.S. Physical Therapy’s $150 Million Common Stock Offering
Latham & Watkins advises the underwriters on US$150 million offering by U.S. Physical Therapy. U.S. Physical Therapy, Inc. has announced that it has priced an underwritten...